Emerald Foundation Inc is located in New York, NY. The organization was established in 1998. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Emerald Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Emerald Foundation Inc generated $1.0m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 9 years, the organization has seen revenues fall by an average of (7.3%) each year. All expenses for the organization totaled $2.2m during the year ending 12/2023. As we would expect to see with falling revenues, expenses have declined by (0.8%) per year over the past 9 years. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Emerald Foundation Inc has awarded 129 individual grants totaling $12,788,719. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
James P Mahaffey Vice President | 40 | $118,750 | |
Andrew W Heymann Pres/director | 8 | $0 | |
Luca Cantelli Director | 0.5 | $0 | |
William Blum Treasurer | 6 | $0 | |
Erika Kellerhals Director | 0.5 | $0 |
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $0 |
| Interest on Savings | $0 |
| Dividends & Interest | $956,828 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $74,802 |
| Capital Gain Net Income | $74,802 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $0 |
| Total Revenue | $1,031,630 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $118,750 |
| Other employee salaries and wages | $0 |
| Pension plans, employee benefits | $3,563 |
| Interest | $0 |
| Taxes | $16,123 |
| Depreciation | $0 |
| Occupancy | $132,000 |
| Travel, conferences, and meetings | $0 |
| Printing and publications | $0 |
| Other expenses | $184,653 |
| Total operating and administrative expenses | $825,249 |
| Contributions, gifts, grants paid | $1,400,000 |
| Total expenses and disbursements | $2,225,249 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $183,659 |
| Savings and temporary cash investments | $478,363 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $0 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $0 |
| Total assets | $26,434,742 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
Over the last fiscal year, Emerald Foundation Inc has awarded $1,400,000 in support to 24 organizations.
| Grant Recipient | Amount |
|---|---|
CA INSTITUTE OF TECHNOLOGY PURPOSE: TO DEVELOP INTERPRETABLE MACHINE LEARNING METHODS THAT LINK SPATIAL PHENOTYPES IN IMAGING DATA OF SOLID TUMORS WITH PATIENT OUTCOMES. | $37,500 |
JOHN HOPKINS UNIVERSITY PURPOSE: TO INVESTIGATE HOW THE COLON MICROBIOTA AND HOST GENETICS INTERSECT TO ALTER RESPONSIVENESS TO IMMUNOTHERAPY IN COLORECTAL CANCER. | $100,000 |
INSTITUTE FOR CANCER RESEARCH PURPOSE: TO INVESTIGATE THE ROLE OF BRG1-DEPENDENT EPIGENETIC REGULATION ON PDAC FIBROBLAST PRO-TUMORIGENIC FUNCTIONS. | $37,500 |
DANA-FARBER CANCER INSTITUTE PURPOSE: TO MAP THE TRANSCRIPTIONAL AND PROTEIN CHANGES INDUCED BY LACTATE AND IDENTIFY THE MECHANISMS THAT CAUSE NK SUPPRESSION, ON BOTH NK AND TUMOR CELLS, USING HIGH-THROUGHPUT AND UNBIASED APPROACHES. | $100,000 |
MA INSTITUTE OF TECHNOLOGY PURPOSE: TO DEVELOP A HIGH-THROUGHPUT SINGLE-CELL GRO-SEQ ASSAY TO EXAMINE THE TUMOR MICROENVIRONMENT ESTABLISHED BY MUTANT-P53 AND DECIPHER THE GENE REGULATORY NETWORKS UNDERLYING PDAC'S INTRANSIGENCE TO IMMUNOTHERAPIES. | $37,500 |
UNIVERSITY OF MD BALTIMORE FOUNDATI PURPOSE: TO INVESTIGATE THE REGULATION OF TREG LYMPHATIC TUMOR MIGRATION AND THE INTERACTION AMONG TREGS, LYMPHATIC ENDOTHELIAL CELLS, AND TUMORS TO DEVELOP STRATEGIES OF DELIVERING TARGETED THERAPIES LOCALLY INSTEAD OF SYSTEMICALLY. | $150,000 |